Annual Gross Profit
$475.89 M
+$79.42 M+20.03%
December 31, 2023
Summary
- As of February 7, 2025, CORT annual gross profit is $475.89 million, with the most recent change of +$79.42 million (+20.03%) on December 31, 2023.
- During the last 3 years, CORT annual gross profit has risen by +$127.60 million (+36.64%).
- CORT annual gross profit is now at all-time high.
Performance
CORT Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$179.68 M
+$18.41 M+11.41%
September 30, 2024
Summary
- As of February 7, 2025, CORT quarterly gross profit is $179.68 million, with the most recent change of +$18.41 million (+11.41%) on September 30, 2024.
- Over the past year, CORT quarterly gross profit has increased by +$35.41 million (+24.54%).
- CORT quarterly gross profit is now at all-time high.
Performance
CORT Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$618.75 M
+$57.72 M+10.29%
September 30, 2024
Summary
- As of February 7, 2025, CORT TTM gross profit is $618.75 million, with the most recent change of +$57.72 million (+10.29%) on September 30, 2024.
- Over the past year, CORT TTM gross profit has increased by +$102.85 million (+19.94%).
- CORT TTM gross profit is now at all-time high.
Performance
CORT TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
CORT Gross Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +20.0% | +24.5% | +19.9% |
3 y3 years | +36.6% | +76.9% | +56.1% |
5 y5 years | +93.4% | +76.9% | +56.1% |
CORT Gross Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +31.9% | at high | +94.4% | at high | +71.5% |
5 y | 5-year | at high | +58.1% | at high | +129.9% | at high | +105.6% |
alltime | all time | at high | -100.0% | at high | -100.0% | at high | -100.0% |
Corcept Therapeutics Incorporated Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $179.68 M(+11.4%) | $618.75 M(+10.3%) |
Jun 2024 | - | $161.27 M(+11.8%) | $561.03 M(+8.7%) |
Mar 2024 | - | $144.27 M(+8.0%) | $515.90 M(+8.4%) |
Dec 2023 | $475.89 M(+20.0%) | $133.53 M(+9.5%) | $475.89 M(+7.2%) |
Sep 2023 | - | $121.96 M(+5.0%) | $443.94 M(+5.1%) |
Jun 2023 | - | $116.14 M(+11.4%) | $422.37 M(+3.4%) |
Mar 2023 | - | $104.27 M(+2.7%) | $408.30 M(+3.0%) |
Dec 2022 | $396.47 M(+9.9%) | $101.58 M(+1.2%) | $396.47 M(+1.0%) |
Sep 2022 | - | $100.39 M(-1.6%) | $392.37 M(+1.4%) |
Jun 2022 | - | $102.07 M(+10.4%) | $386.83 M(+3.2%) |
Mar 2022 | - | $92.44 M(-5.2%) | $374.97 M(+4.0%) |
Dec 2021 | $360.70 M(+3.6%) | $97.47 M(+2.8%) | $360.70 M(+3.7%) |
Sep 2021 | - | $94.86 M(+5.2%) | $347.71 M(+2.9%) |
Jun 2021 | - | $90.20 M(+15.4%) | $337.96 M(+0.9%) |
Mar 2021 | - | $78.17 M(-7.5%) | $335.09 M(-3.8%) |
Dec 2020 | $348.29 M(+15.7%) | $84.48 M(-0.7%) | $348.29 M(-0.6%) |
Sep 2020 | - | $85.11 M(-2.5%) | $350.27 M(+1.5%) |
Jun 2020 | - | $87.33 M(-4.4%) | $345.21 M(+5.0%) |
Mar 2020 | - | $91.37 M(+5.7%) | $328.76 M(+9.2%) |
Dec 2019 | $300.98 M(+22.3%) | $86.46 M(+8.0%) | $300.98 M(+7.6%) |
Sep 2019 | - | $80.05 M(+12.9%) | $279.77 M(+6.4%) |
Jun 2019 | - | $70.88 M(+11.5%) | $262.86 M(+3.8%) |
Mar 2019 | - | $63.59 M(-2.5%) | $253.14 M(+2.9%) |
Dec 2018 | $246.03 M(+58.1%) | $65.25 M(+3.3%) | $246.03 M(+5.6%) |
Sep 2018 | - | $63.14 M(+3.2%) | $232.90 M(+10.1%) |
Jun 2018 | - | $61.16 M(+8.3%) | $211.55 M(+14.2%) |
Mar 2018 | - | $56.48 M(+8.4%) | $185.18 M(+19.0%) |
Dec 2017 | $155.65 M(+96.4%) | $52.12 M(+24.7%) | $155.65 M(+22.8%) |
Sep 2017 | - | $41.79 M(+20.1%) | $126.78 M(+19.5%) |
Jun 2017 | - | $34.78 M(+29.1%) | $106.05 M(+17.1%) |
Mar 2017 | - | $26.95 M(+15.9%) | $90.56 M(+14.2%) |
Dec 2016 | $79.26 M | $23.25 M(+10.4%) | $79.26 M(+12.2%) |
Sep 2016 | - | $21.06 M(+9.1%) | $70.62 M(+12.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2016 | - | $19.30 M(+23.2%) | $62.56 M(+14.2%) |
Mar 2016 | - | $15.66 M(+7.2%) | $54.78 M(+12.0%) |
Dec 2015 | $48.92 M(+90.6%) | $14.60 M(+12.3%) | $48.92 M(+13.6%) |
Sep 2015 | - | $13.01 M(+12.9%) | $43.08 M(+16.1%) |
Jun 2015 | - | $11.52 M(+17.5%) | $37.12 M(+18.8%) |
Mar 2015 | - | $9.80 M(+11.9%) | $31.24 M(+21.7%) |
Dec 2014 | $25.67 M(+151.3%) | $8.76 M(+24.3%) | $25.67 M(+22.4%) |
Sep 2014 | - | $7.05 M(+25.0%) | $20.97 M(+27.0%) |
Jun 2014 | - | $5.64 M(+33.2%) | $16.52 M(+29.6%) |
Mar 2014 | - | $4.23 M(+4.4%) | $12.75 M(+24.8%) |
Dec 2013 | $10.21 M(+217.6%) | $4.05 M(+56.3%) | $10.21 M(+35.9%) |
Sep 2013 | - | $2.59 M(+38.9%) | $7.52 M(+26.3%) |
Jun 2013 | - | $1.87 M(+10.1%) | $5.95 M(+21.2%) |
Mar 2013 | - | $1.70 M(+25.0%) | $4.91 M(+52.8%) |
Dec 2012 | $3.22 M(>+9900.0%) | $1.36 M(+31.7%) | $3.22 M(+73.1%) |
Sep 2012 | - | $1.03 M(+24.7%) | $1.86 M(+124.7%) |
Jun 2012 | - | $827.00 K(>+9900.0%) | $827.00 K(>+9900.0%) |
Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
Mar 2010 | - | $0.00(0.0%) | $6000.00(-80.0%) |
Dec 2009 | $29.00 K(-86.1%) | $0.00(0.0%) | $30.00 K(-82.7%) |
Sep 2009 | - | $0.00(-100.0%) | $173.00 K(-27.6%) |
Jun 2009 | - | $6000.00(-75.0%) | $239.00 K(+2.6%) |
Mar 2009 | - | $24.00 K(-83.2%) | $233.00 K(+11.5%) |
Dec 2008 | $209.00 K(-56.6%) | $143.00 K(+116.7%) | $209.00 K(+216.7%) |
Sep 2008 | - | $66.00 K | $66.00 K |
Dec 2007 | $482.00 K | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual gross profit?
- What is the all time high annual gross profit for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual gross profit year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly gross profit?
- What is the all time high quarterly gross profit for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly gross profit year-on-year change?
- What is Corcept Therapeutics Incorporated TTM gross profit?
- What is the all time high TTM gross profit for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM gross profit year-on-year change?
What is Corcept Therapeutics Incorporated annual gross profit?
The current annual gross profit of CORT is $475.89 M
What is the all time high annual gross profit for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual gross profit is $475.89 M
What is Corcept Therapeutics Incorporated annual gross profit year-on-year change?
Over the past year, CORT annual gross profit has changed by +$79.42 M (+20.03%)
What is Corcept Therapeutics Incorporated quarterly gross profit?
The current quarterly gross profit of CORT is $179.68 M
What is the all time high quarterly gross profit for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly gross profit is $179.68 M
What is Corcept Therapeutics Incorporated quarterly gross profit year-on-year change?
Over the past year, CORT quarterly gross profit has changed by +$35.41 M (+24.54%)
What is Corcept Therapeutics Incorporated TTM gross profit?
The current TTM gross profit of CORT is $618.75 M
What is the all time high TTM gross profit for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM gross profit is $618.75 M
What is Corcept Therapeutics Incorporated TTM gross profit year-on-year change?
Over the past year, CORT TTM gross profit has changed by +$102.85 M (+19.94%)